← Evidence map

ArticleFrontiers in oncology2024

CRISPR-based molecule-regulatory expression platform for specific immunotherapy of cancer.

Tianying Zhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39507755